The world's first human trial of a drug that can regenerate teeth will begin in a few months, less than a year on from news of its success in animals. This paves the way for the medicine to be commercially available as early as 2030.
ADepending on the science being done, genders are preferred. In many cases it’s men due to less complex chemistry and internal anatomy. Men are more basic to start off with less risk of imbalance or damage if things go unexpectedly. Considering the nature of what’s being done, this isn’t at all odd for this trial. Sciences doesn’t recognise gender bias unless it’s studying gender bias.
ADepending on the science being done, genders are preferred. In many cases it’s men due to less complex chemistry and internal anatomy. Men are more basic to start off with less risk of imbalance or damage if things go unexpectedly. Considering the nature of what’s being done, this isn’t at all odd for this trial. Sciences doesn’t recognise gender bias unless it’s studying gender bias.